Daily Washington Insider
  • Business
  • World
  • Science
  • Investing

Daily Washington Insider

  • Business
  • World
  • Science
  • Investing
Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025
June 4, 2025
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
5 Biggest Blockchain ETFs in 2025
next post
Several feared dead in a crowd crush outside a cricket stadium in India

You may also like

Glencore Pursues Argentina Incentives for US$13.5 Billion Copper...

August 21, 2025

With Step-Out Drilling Continuing, Radisson Demonstrates Meaningful Resource...

March 2, 2026

Gold and Silver Prices End Week Lower as...

June 1, 2024

Announcement by Cyclone Metals Ltd

November 22, 2024

Tech Weekly: Mega-cap Earnings Dominate Narrow Trading Week

January 31, 2026

EV Market Forecast: Top Trends for EVs in...

January 1, 2025

DFS Investor Webinar Presentation

July 2, 2025

U.S. Investors Lead Oversubscribed $17m Placement

December 8, 2025

InMed Pharmaceuticals

November 18, 2025

GM Strengthens Lithium Supply Chain with US$625 Million...

October 19, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Popular

    • 1

      Hong Kong plans to install thousands of surveillance cameras. Critics say it’s...

    • 2

      UN experts urge Thailand not to deport dozens of Uyghurs to China where they face ‘real risk of torture’

    • 3

      Trump has assembled a team of China hawks. How will Beijing respond?

    • 4

      China executes man who plowed car into crowds in deadliest attack in a decade

    • 5

      How Calvin Klein and Tommy Hilfiger got caught in Trump’s trade war with China

    Categories

    • Business (1,458)
    • Investing (4,835)
    • Science (627)
    • World (3,687)
    Footer Logo
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: dailywashingtoninsider.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 dailywashingtoninsider.com | All Rights Reserved